Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on May 27, 2024 5:19am
RE:RE:RE:RE:RE:NDA approval
Greed
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on May 24, 2024 9:52am
RE:RE:RE:RE:NDA approval
FWIW, I'm not fed up or giving up. I just dislike people spewing their aspirations as fact. LABS is really a hidden gem IMO and ought take off. But something is holding it back
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on May 24, 2024 9:48am
RE:RE:RE:RE:RE:NDA approval
asks are way down this morning with a bit of volume we could see a decent move north 700k will take us to $.10
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on May 24, 2024 9:22am
RE:RE:RE:RE:NDA approval
Not giving up s1, just busy with spring stuff. Investing in Labs is a marathon, not a sprint and so far q after q numbers are improving, so its only a matter of time before the market starts to
...more
(758)
•••
Danno13
X
View Profile
View Bullboard History
Post by
Danno13
on May 24, 2024 7:00am
Science & Health
/ SCIENCE & HEALTH A study found that CBD "ameliorates PTSD-like symptoms by inhibiting
...more
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on May 24, 2024 3:50am
RE:RE:RE:RE:NDA approval
Always pile low... When approval comes and the market recognizes that Labs has full market access in the US, the stock price won't be at 0.25 cents... as previously stated, Pidduck said in the CC
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on May 23, 2024 7:38pm
RE:RE:RE:NDA approval
Well, may be you 3 guys are like fed up of waiting and waiting so you are giving up, i know Alleyesonme that you have at least another stock that is not doing to well either so it is not easy for many
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on May 23, 2024 1:21pm
RE:RE:NDA approval
Lastly, get ready for the I told you so, much like the one given to the naysayers about the ANDA, and it being for epidiolex...dejavoo.
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on May 23, 2024 1:15pm
RE:NDA approval
Those who've been invested, go through the financials quarterly, listen to the CC's, know what is happening, at no time do you think to postmark certain statements to later reference on a
...more
(100)
•••
Solid1
X
View Profile
View Bullboard History
Post by
Solid1
on May 23, 2024 10:46am
NDA approval
The approval of the NDA can come at any time - it was already submitted in Q3 2022!
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on May 23, 2024 10:22am
RE:RE:they took shares in tilray
. Lol
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on May 23, 2024 10:18am
RE:RE:they took shares in tilray
Is it July 2024 yet?
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on May 23, 2024 10:12am
RE:RE:RE:RE:RE:RE:Investor attitude toward management
You have clearly shown that you do NOT err on the side of caution and peddle your version of truth without validation. But by all means, ask the business about their NDA efforts (not ANDA) and
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on May 23, 2024 9:34am
RE:RE:RE:RE:RE:Investor attitude toward management
I totally concur with you Q...... trying to read the tealeafs can be very dangerous. I held stock in a company that invented a detector during Covid, not a fly by night outfit they are in
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >